Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The antibody molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.
申请公布号
CA2721032(A1)
申请公布日期
2009.10.22
申请号
CA20092721032
申请日期
2009.04.17
申请人
FUSION ANTIBODIES LIMITED
发明人
CASWELL, JILL;OLWILL, SHANE;JOHNSTON, JAMES;BUICK, RICHARD;JAQUIN, THOMAS;DOHERTY, DECLAN;SCOTT, CHRISTOPHER
